Journal of the Neurological Sciences
Volume 283, Issue 1 , Pages 199-206 , 15 August 2009

The effect of acetyl-L-carnitine and R-α-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease

  • Justin C. Shenk

      Affiliations

    • Department of Biology and Electron Microscopy Research Center, University of Texas at San Antonio, San Antonio, TX, 78249, USA
    • ,
  • Jiankang Liu

      Affiliations

    • Children's Hospital Oakland Research Institute, Oakland, CA 94609, USA
    • ,
  • Kathryn Fischbach

      Affiliations

    • Department of Biology and Electron Microscopy Research Center, University of Texas at San Antonio, San Antonio, TX, 78249, USA
    • ,
  • Kui Xu

      Affiliations

    • Department of Anatomy, School of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA
    • ,
  • Michel Puchowicz

      Affiliations

    • Department of Anatomy, School of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA
    • ,
  • Mark E. Obrenovich

      Affiliations

    • Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA
    • ,
  • Eldar Gasimov

      Affiliations

    • Department of Cytology, Histology and Embryology, Baku Medical University, Baku, AZ10-25, Azerbaijan
    • ,
  • Ludis Morales Alvarez

      Affiliations

    • Department of Nutrition and Biochemistry, University of Javeriana, Bogota, Colombia
    • ,
  • Bruce N. Ames

      Affiliations

    • Children's Hospital Oakland Research Institute, Oakland, CA 94609, USA
    • ,
  • Joseph C. LaManna

      Affiliations

    • Department of Anatomy, School of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA
    • ,
  • Gjumrakch Aliev

      Affiliations

    • Department of Biology and Electron Microscopy Research Center, University of Texas at San Antonio, San Antonio, TX, 78249, USA
    • Corresponding Author InformationCorresponding author. Department of Biology, College of Sciences & Electron Microscopy Research Center, The University of Texas at San Antonio, One UTSA Circle, San Antonio, TX 78249-1664, USA. Tel.: +1 440 263 7461.

References 

  1. de la Torre JC. Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis. Neurobiol Aging. 2000;21:331–342
  2. de la Torre JC, Stefano GB. Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide. Brain Res Brain Res Rev. 2000;34:119–136
  3. Etiene D, Kraft J, Ganju N, Gomez-Isla T, Gemelli B, Hyman BT, et al. Cerebrovascular pathology contributes to the heterogeneity of Alzheimer's disease. J Alzheimers Dis. 1998;1:119–134
  4. Kalaria RN, Ballard C. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord. 1999;13(Suppl 3):S115–S123
  5. Kalaria RN. The blood–brain barrier and cerebrovascular pathology in Alzheimer's disease. Ann N Y Acad Sci. 1999;893:113–125
  6. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988;240:622–630
  7. Weisgraber KH, Pitas RE, Mahley RW. Lipoproteins, neurobiology, and Alzheimer's disease: structure and function of apolipoprotein E. Curr Opin Struct Biol. 1994;4:507–515
  8. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 1993;342:697–699
  9. Boyles JK, Zoellner CD, Anderson LJ, Kosik LM, Pitas RE, Weisgraber KH, et al. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest. 1989;83:1015–1031
  10. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90:9649–9653
  11. Holtzman DM, Bales KR, Tenkova T, Fagan AM, Parsadanian M, Sartorius LJ, et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A. 2000;97:2892–2897
  12. Heeschen C, Jang JJ, Weis M, Pathak A, Kaji S, Hu RS, et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med. 2001;7:833–839
  13. Walker LC, Parker CA, Pipinski WJ, Callahan MJ, Carroll RT, Gandy SE, et al. Cerebral lipid deposition in aged apolipoprotein-E-deficient mice. Am J Pathol. 1997;151:1371–1377
  14. Fisher A, Brandeis R, Chapman S, Pittel Z, Michaelson DM. M1 muscarinic agonist treatment reverses cognitive and cholinergic impairments of apolipoprotein E-deficient mice. J Neurochem. 1998;70:1991–1997
  15. Genis I, Michaelson DM. Hyperphosphorylation of tau in apolipoprotein E-deficient mice. In: al. Fe, editor. Progress in Alzheimer's and Parkinson's diseases. New York: Plenum Press; 1998. p. 251–256.
  16. Sparks DL. Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease?. Ann N Y Acad Sci. 1997;826:128–146
  17. Fullerton SM, Shirman GA, Strittmatter WJ, Matthew WD. Impairment of the blood–nerve and blood–brain barriers in apolipoprotein E knockout mice. Exp Neurol. 2001;169:13–22
  18. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta analysis consortium. jAMA. 1997;278:1349–1356
  19. Trogan E, Choudhury RP, Dansky HM, Rong JX, Breslow JL, Fisher EA. Laser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A. 2002;99:2234–2239
  20. Bales KR, Verina T, Cummins DJ, Du Y, Dodel RC, Saura J, et al. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A. 1999;96:15233–15238
  21. Aliev G, Smith MA, Turmaine M, Neal ML, Zimina TV, Friedland RP, et al. Atherosclerotic lesions are associated with increased immunoreactivity for inducible nitric oxide synthase and endothelin-1 in thoracic aortic intimal cells of hyperlipidemic Watanabe rabbits. Exp Mol Pathol. 2001;71:40–54
  22. Aliev G, Smith MA, Obrenovich ME, de la Torre JC, Perry G. Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease. Neurotox Res. 2003;5:491–504
  23. Aliev G, Smith MA, Seyidov D, Neal ML, Lamb BT, Nunomura A, et al. The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease. Brain Pathol. 2002;12:21–35
  24. Jagust WJ, Eberling JL, Reed BR, Mathis CA, Budinger TF. Clinical studies of cerebral blood flow in Alzheimer's disease. Ann N Y Acad Sci. 1997;826:254–262
  25. Jagust WJ, Friedland RP, Budinger TF, Koss E, Ober B. Longitudinal studies of regional cerebral metabolism in Alzheimer's disease. Neurology. 1988;38:909–912
  26. Blain JF, Poirier J. Cholesterol homeostasis and the pathophysiology of Alzheimer's disease. Expert Rev Neurother. 2004;4:823–829
  27. de la Torre JC. Vascular basis of Alzheimer's pathogenesis. Ann N Y Acad Sci. 2002;977:196–215
  28. de la Torre JC. Alzheimer's disease: how does it start?. J Alzheimers Dis. 2002;4:497–512
  29. de la Torre JC. Alzheimer disease as a vascular disorder: nosological evidence. Stroke. 2002;33:1152–1162
  30. Lim GP, Calon F, Morihara T, Yang F, Teter B, Ubeda O, et al. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci. 2005;25:3032–3040
  31. Aliyev A, Chen SG, Seyidova D, Smith MA, Perry G, de la Torre J, et al. Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease. J Neurol Sci. 2005;229–230:285–292
  32. Meguro K, Blaizot X, Kondoh Y, Le Mestric C, Baron JC, Chavoix C. Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease. Brain. 1999;122(Pt 8):1519–1531
  33. Beal MF. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol. 1995;38:357–366
  34. Aliev G, Seyidova D, Neal ML, Shi J, Lamb BT, Siedlak SL, et al. Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice. Ann N Y Acad Sci. 2002;977:45–64
  35. Markesbery WR. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med. 1997;23:134–147
  36. Reiman EM, Caselli RJ, Chen K, Alexander GE, Bandy D, Frost J. Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc Natl Acad Sci U S A. 2001;98:3334–3339
  37. Alves TC, Rays J, Fraguas R, Wajngarten M, Meneghetti JC, Prando S, et al. Localized cerebral blood flow reductions in patients with heart failure: a study using 99mTc-HMPAO SPECT. J Neuroimaging. 2005;15:150–156
  38. Aliev G, Seyidova D, Lamb BT, Obrenovich ME, Siedlak SL, Vinters HV, et al. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice. Neurol Res. 2003;25:665–674
  39. Obrenovich ME, Smith MA, Siedlak SL, Chen SG, de la Torre JC, Perry G, et al. Overexpression of GRK2 in Alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions. Neurotox Res. 2006;10:43–56
  40. Liu J, Head E, Gharib AM, Yuan W, Ingersoll RT, Hagen TM, et al. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-alpha -lipoic acid. Proc Natl Acad Sci U S A. 2002;99:2356–2361
  41. Aliev G, Liu J, Shenk JC, Fischbach K, Pacheco GJ, Chen SG, et al. Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats. J Cell Mol Med. 2009;13:320–333[Epub ahead of print, Mar 29, 2008]
  42. Puchowicz MA, Radhakrishnan K, Xu K, Magness DL, LaManna JC. Computational study on use of single-point analysis method for quantitating local cerebral blood flow in mice. Adv Exp Med Biol. 2005;566:99–104
  43. Aliev G, Puchowicz M, Xu K, Shenk JC, Smith MA, Siedlak SL, et al. ApoE deficiency induces age-dependent brain hypoperfusion and neuronal-glial and microvascular damage in mice. ApoE deficiency induces hypoperfusion that initiate age-dependent decreases in cerebral blood flow and microvessels lesions. 2007;4(Suppl 1):182
  44. Schenk F, Morris RG. Dissociation between components of spatial memory in rats after recovery from the effects of retrohippocampal lesions. Exp Brain Res. 1985;58:11–28
  45. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods. 1984;11:47–60
  46. Liu J, Killilea DW, Ames BN. Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L-carnitine and/or R-alpha-lipoic acid. Proc Natl Acad Sci U S A. 2002;99:1876–1881
  47. Roberts S. Isolation of an internal clock. J Exp Psychol Anim Behav Process. 1981;7:242–268
  48. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, et al. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci. 2001;21:3017–3023
  49. Aliev G, Castellani RJ, Petersen RB, Burnstock G, Perry G, Smith MA. Pathobiology of familial hypercholesterolemic atherosclerosis. J Submicrosc Cytol Pathol. 2004;36:225–240
  50. Aliev G, Smith MA, Obrenovich ME, Perry G. Role of vascular hypoperfusion-induced oxidative stress and mitochondrial failure in the pathogenesis of Alzheimer disease. Neurotox Res. 2003;5:385–390
  51. Aliev G, Smith MA, de la Torre JC, Perry G. Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease. Mitochondrion. 2004;4:649–663
  52. Causes, early detection, treatment, models, prevention, risk factors. 2002;[cited; Available from: http://www.alz.org/Researchers/RGP/Biological.htm
  53. Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A. 2006;103:5644–5651
  54. Perry G, Nunomura A, Hirai K, Zhu X, Perez M, Avila J, et al. Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases?. Free Radic Biol Med. 2002;33:1475–1479
  55. de la Torre JC, Aliev G. Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: spatial memory and immunocytochemical changes. J Cereb Blood Flow Metab. 2005;25:663–672
  56. Aliev G, Perry G, Shenk J, Puchowicz M, Xu K, Siedlak SL, et al. The primary pathogenetic role of vascular hypoperfusion, and oxidative stress in Alzheimer disease. Atheroscler Suppl. 2007;8:105
  57. Aliyev A, Seyidova D, Rzayev N, Obrenovich ME, Lamb BT, Chen SG, et al. Is nitric oxide a key target in the pathogenesis of brain lesions during the development of Alzheimer's disease?. Neurol Res. 2004;26:547–553
  58. Castellani R, Hirai K, Aliev G, Drew KL, Nunomura A, Takeda A, et al. Role of mitochondrial dysfunction in Alzheimer's disease. J Neurosci Res. 2002;70:357–360
  59. Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, et al. Autophagocytosis of mitochondria is prominent in Alzheimer disease. J Neuropathol Exp Neurol. 2007;66:525–532
  60. Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, et al. Increased autophagic degradation of mitochondria in Alzheimer disease. Autophagy. 2007;3

PII: S0022-510X(09)00491-2

doi: 10.1016/j.jns.2009.03.002

Journal of the Neurological Sciences
Volume 283, Issue 1 , Pages 199-206 , 15 August 2009

Article Tools

* Image Usage & Resolution